RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Jose L. Lopez-Ribot to Biofilms

Back to Details
This is a "connection" page, showing publications Jose L. Lopez-Ribot has written about Biofilms.
Jose L. Lopez-Ribot
Connection Strength
15.419
Biofilms
  1. Lara HH, Ixtepan-Turrent L, Jose Yacaman M, Lopez-Ribot J. Inhibition of Candida auris Biofilm Formation on Medical and Environmental Surfaces by Silver Nanoparticles. ACS Appl Mater Interfaces. 2020 May 13; 12(19):21183-21191.
    View in: PubMed
    Score: 0.617
  2. Montelongo-Jauregui D, Saville SP, Lopez-Ribot JL. Contributions of Candida albicans Dimorphism, Adhesive Interactions, and Extracellular Matrix to the Formation of Dual-Species Biofilms with Streptococcus gordonii. mBio. 2019 06 18; 10(3).
    View in: PubMed
    Score: 0.592
  3. Romo JA, Pierce CG, Esqueda M, Hung CY, Saville SP, Lopez-Ribot JL. In Vitro Characterization of a Biaryl Amide Anti-virulence Compound Targeting Candida albicans Filamentation and Biofilm Formation. Front Cell Infect Microbiol. 2018; 8:227.
    View in: PubMed
    Score: 0.555
  4. Romo JA, Pierce CG, Chaturvedi AK, Lazzell AL, McHardy SF, Saville SP, Lopez-Ribot JL. Development of Anti-Virulence Approaches for Candidiasis via a Novel Series of Small-Molecule Inhibitors of Candida albicans Filamentation. mBio. 2017 Dec 05; 8(6).
    View in: PubMed
    Score: 0.533
  5. Vila T, Lopez-Ribot JL. Screening the Pathogen Box for Identification of Candida albicans Biofilm Inhibitors. Antimicrob Agents Chemother. 2017 01; 61(1).
    View in: PubMed
    Score: 0.499
  6. Uppuluri P, Lopez-Ribot JL. Go Forth and Colonize: Dispersal from Clinically Important Microbial Biofilms. PLoS Pathog. 2016 Feb; 12(2):e1005397.
    View in: PubMed
    Score: 0.470
  7. Vila TV, Chaturvedi AK, Rozental S, Lopez-Ribot JL. In Vitro Activity of Miltefosine against Candida albicans under Planktonic and Biofilm Growth Conditions and In Vivo Efficacy in a Murine Model of Oral Candidiasis. Antimicrob Agents Chemother. 2015 Dec; 59(12):7611-20.
    View in: PubMed
    Score: 0.458
  8. Pierce CG, Srinivasan A, Ramasubramanian AK, L?pez-Ribot JL. From Biology to Drug Development: New Approaches to Combat the Threat of Fungal Biofilms. Microbiol Spectr. 2015 Jun; 3(3).
    View in: PubMed
    Score: 0.447
  9. Lopez-Ribot JL. Large-scale biochemical profiling of the Candida albicans biofilm matrix: new compositional, structural, and functional insights. mBio. 2014 Sep 09; 5(5):e01781-14.
    View in: PubMed
    Score: 0.426
  10. Pierce CG, Saville SP, Lopez-Ribot JL. High-content phenotypic screenings to identify inhibitors of Candida albicans biofilm formation and filamentation. Pathog Dis. 2014 Apr; 70(3):423-31.
    View in: PubMed
    Score: 0.411
  11. Sarkar S, Uppuluri P, Pierce CG, Lopez-Ribot JL. In vitro study of sequential fluconazole and caspofungin treatment against Candida albicans biofilms. Antimicrob Agents Chemother. 2014; 58(2):1183-6.
    View in: PubMed
    Score: 0.402
  12. Pierce CG, Srinivasan A, Uppuluri P, Ramasubramanian AK, L?pez-Ribot JL. Antifungal therapy with an emphasis on biofilms. Curr Opin Pharmacol. 2013 Oct; 13(5):726-30.
    View in: PubMed
    Score: 0.397
  13. Uppuluri P, Srinivasan A, Ramasubramanian A, Lopez-Ribot JL. Effects of fluconazole, amphotericin B, and caspofungin on Candida albicans biofilms under conditions of flow and on biofilm dispersion. Antimicrob Agents Chemother. 2011 Jul; 55(7):3591-3.
    View in: PubMed
    Score: 0.337
  14. Uppuluri P, Lopez-Ribot JL. An easy and economical in vitro method for the formation of Candida albicans biofilms under continuous conditions of flow. Virulence. 2010 Nov-Dec; 1(6):483-7.
    View in: PubMed
    Score: 0.326
  15. Pierce CG, Uppuluri P, Tummala S, Lopez-Ribot JL. A 96 well microtiter plate-based method for monitoring formation and antifungal susceptibility testing of Candida albicans biofilms. J Vis Exp. 2010 Oct 21; (44).
    View in: PubMed
    Score: 0.325
  16. Uppuluri P, Pierce CG, Thomas DP, Bubeck SS, Saville SP, Lopez-Ribot JL. The transcriptional regulator Nrg1p controls Candida albicans biofilm formation and dispersion. Eukaryot Cell. 2010 Oct; 9(10):1531-7.
    View in: PubMed
    Score: 0.321
  17. Uppuluri P, Chaturvedi AK, Srinivasan A, Banerjee M, Ramasubramaniam AK, K?hler JR, Kadosh D, Lopez-Ribot JL. Dispersion as an important step in the Candida albicans biofilm developmental cycle. PLoS Pathog. 2010 Mar 26; 6(3):e1000828.
    View in: PubMed
    Score: 0.312
  18. Uppuluri P, Pierce CG, L?pez-Ribot JL. Candida albicans biofilm formation and its clinical consequences. Future Microbiol. 2009 Dec; 4(10):1235-7.
    View in: PubMed
    Score: 0.306
  19. Uppuluri P, Dinakaran H, Thomas DP, Chaturvedi AK, Lopez-Ribot JL. Characteristics of Candida albicans biofilms grown in a synthetic urine medium. J Clin Microbiol. 2009 Dec; 47(12):4078-83.
    View in: PubMed
    Score: 0.302
  20. Lazzell AL, Chaturvedi AK, Pierce CG, Prasad D, Uppuluri P, Lopez-Ribot JL. Treatment and prevention of Candida albicans biofilms with caspofungin in a novel central venous catheter murine model of candidiasis. J Antimicrob Chemother. 2009 Sep; 64(3):567-70.
    View in: PubMed
    Score: 0.297
  21. Redding S, Bhatt B, Rawls HR, Siegel G, Scott K, Lopez-Ribot J. Inhibition of Candida albicans biofilm formation on denture material. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 May; 107(5):669-72.
    View in: PubMed
    Score: 0.294
  22. Uppuluri P, Chaturvedi AK, Lopez-Ribot JL. Design of a simple model of Candida albicans biofilms formed under conditions of flow: development, architecture, and drug resistance. Mycopathologia. 2009 Sep; 168(3):101-9.
    View in: PubMed
    Score: 0.293
  23. Ramage G, Mowat E, Jones B, Williams C, Lopez-Ribot J. Our current understanding of fungal biofilms. Crit Rev Microbiol. 2009; 35(4):340-55.
    View in: PubMed
    Score: 0.287
  24. Pierce CG, Thomas DP, L?pez-Ribot JL. Effect of tunicamycin on Candida albicans biofilm formation and maintenance. J Antimicrob Chemother. 2009 Mar; 63(3):473-9.
    View in: PubMed
    Score: 0.286
  25. Ramage G, Wickes BL, L?pez-Ribot JL. A seed and feed model for the formation of Candida albicans biofilms under flow conditions using an improved modified Robbins device. Rev Iberoam Micol. 2008 Mar; 25(1):37-40.
    View in: PubMed
    Score: 0.271
  26. Pierce CG, Uppuluri P, Tristan AR, Wormley FL, Mowat E, Ramage G, Lopez-Ribot JL. A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat Protoc. 2008; 3(9):1494-500.
    View in: PubMed
    Score: 0.268
  27. Ramage G, Wickes BL, L?pez-Ribot JL. Inhibition on Candida albicans biofilm formation using divalent cation chelators (EDTA). Mycopathologia. 2007 Dec; 164(6):301-6.
    View in: PubMed
    Score: 0.263
  28. Thomas DP, Bachmann SP, Lopez-Ribot JL. Proteomics for the analysis of the Candida albicans biofilm lifestyle. Proteomics. 2006 Nov; 6(21):5795-804.
    View in: PubMed
    Score: 0.247
  29. Ramage G, Mart?nez JP, L?pez-Ribot JL. Candida biofilms on implanted biomaterials: a clinically significant problem. FEMS Yeast Res. 2006 Nov; 6(7):979-86.
    View in: PubMed
    Score: 0.247
  30. Ramage G, Saville SP, Thomas DP, L?pez-Ribot JL. Candida biofilms: an update. Eukaryot Cell. 2005 Apr; 4(4):633-8.
    View in: PubMed
    Score: 0.221
  31. Ramage G, L?pez-Ribot JL. Techniques for antifungal susceptibility testing of Candida albicans biofilms. Methods Mol Med. 2005; 118:71-9.
    View in: PubMed
    Score: 0.217
  32. Bachmann SP, Ramage G, VandeWalle K, Patterson TF, Wickes BL, L?pez-Ribot JL. Antifungal combinations against Candida albicans biofilms in vitro. Antimicrob Agents Chemother. 2003 Nov; 47(11):3657-9.
    View in: PubMed
    Score: 0.201
  33. Ajetunmobi OH, Chaturvedi AK, Badali H, Vaccaro A, Najvar L, Wormley FL, Wiederhold NP, Patterson TF, Lopez-Ribot JL. Screening the medicine for malaria venture's Pandemic Response Box to identify novel inhibitors of Candida albicans and Candida auris biofilm formation. APMIS. 2023 Nov; 131(11):613-625.
    View in: PubMed
    Score: 0.195
  34. Ramage G, Borghi E, Rodrigues CF, Kean R, Williams C, Lopez-Ribot J. Our current clinical understanding of Candida biofilms: where are we two decades on? APMIS. 2023 Nov; 131(11):636-653.
    View in: PubMed
    Score: 0.192
  35. Ajetunmobi OH, Wall G, Bonifacio BV, Montelongo-Jauregui D, Lopez-Ribot JL. A 384-Well Microtiter Plate Model for Candida Biofilm Formation and Its Application to High-Throughput Screening. Methods Mol Biol. 2023; 2658:53-64.
    View in: PubMed
    Score: 0.189
  36. Bachmann SP, VandeWalle K, Ramage G, Patterson TF, Wickes BL, Graybill JR, L?pez-Ribot JL. In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob Agents Chemother. 2002 Nov; 46(11):3591-6.
    View in: PubMed
    Score: 0.187
  37. Ramage G, Saville SP, Wickes BL, L?pez-Ribot JL. Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule. Appl Environ Microbiol. 2002 Nov; 68(11):5459-63.
    View in: PubMed
    Score: 0.187
  38. Ramage G, Bachmann S, Patterson TF, Wickes BL, L?pez-Ribot JL. Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms. J Antimicrob Chemother. 2002 Jun; 49(6):973-80.
    View in: PubMed
    Score: 0.182
  39. Ramage G, Vande Walle K, Wickes BL, L?pez-Ribot JL. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother. 2001 Sep; 45(9):2475-9.
    View in: PubMed
    Score: 0.173
  40. Ramage G, Vande Walle K, Wickes BL, L?pez-Ribot JL. Biofilm formation by Candida dubliniensis. J Clin Microbiol. 2001 Sep; 39(9):3234-40.
    View in: PubMed
    Score: 0.173
  41. Ramage G, Wickes BL, Lopez-Ribot JL. Biofilms of Candida albicans and their associated resistance to antifungal agents. Am Clin Lab. 2001 Aug; 20(7):42-4.
    View in: PubMed
    Score: 0.172
  42. Cheng T, Torres NS, Chen P, Srinivasan A, Cardona S, Lee GC, Leung KP, Lopez-Ribot JL, Ramasubramanian AK. A Facile High-Throughput Model of Surface-Independent Staphylococcus aureus Biofilms by Spontaneous Aggregation. mSphere. 2021 04 28; 6(2).
    View in: PubMed
    Score: 0.168
  43. Wall G, Chen E, Hull MV, Lopez-Ribot JL. Screening the CALIBR ReFRAME Library in Search for Inhibitors of Candida auris Biofilm Formation. Front Cell Infect Microbiol. 2020; 10:597931.
    View in: PubMed
    Score: 0.164
  44. Romo JA, Zhang H, Cai H, Kadosh D, Koehler JR, Saville SP, Wang Y, Lopez-Ribot JL. Global Transcriptomic Analysis of the Candida albicans Response to Treatment with a Novel Inhibitor of Filamentation. mSphere. 2019 09 11; 4(5).
    View in: PubMed
    Score: 0.150
  45. Wall G, Montelongo-Jauregui D, Vidal Bonifacio B, Lopez-Ribot JL, Uppuluri P. Candida albicans biofilm growth and dispersal: contributions to pathogenesis. Curr Opin Microbiol. 2019 12; 52:1-6.
    View in: PubMed
    Score: 0.147
  46. Dekkerov? J, Lopez-Ribot JL, Bujd?kov? H. Activity of anti-CR3-RP polyclonal antibody against biofilms formed by Candida auris, a multidrug-resistant emerging fungal pathogen. Eur J Clin Microbiol Infect Dis. 2019 Jan; 38(1):101-108.
    View in: PubMed
    Score: 0.141
  47. Lara HH, Guisbiers G, Mendoza J, Mimun LC, Vincent BA, Lopez-Ribot JL, Nash KL. Synergistic antifungal effect of chitosan-stabilized selenium nanoparticles synthesized by pulsed laser ablation in liquids against Candida albicans biofilms. Int J Nanomedicine. 2018; 13:2697-2708.
    View in: PubMed
    Score: 0.137
  48. Lara HH, Romero-Urbina DG, Pierce C, Lopez-Ribot JL, Arellano-Jim?nez MJ, Jose-Yacaman M. Effect of silver nanoparticles on Candida albicans biofilms: an ultrastructural study. J Nanobiotechnology. 2015 Dec 15; 13:91.
    View in: PubMed
    Score: 0.116
  49. Srinivasan A, Gupta CM, Agrawal CM, Leung KP, Lopez-Ribot JL, Ramasubramanian AK. Drug susceptibility of matrix-encapsulated Candida albicans nano-biofilms. Biotechnol Bioeng. 2014 Feb; 111(2):418-24.
    View in: PubMed
    Score: 0.100
  50. Srinivasan A, Leung KP, Lopez-Ribot JL, Ramasubramanian AK. High-throughput nano-biofilm microarray for antifungal drug discovery. mBio. 2013 Jun 25; 4(4).
    View in: PubMed
    Score: 0.098
  51. Pierce CG, Lopez-Ribot JL. Candidiasis drug discovery and development: new approaches targeting virulence for discovering and identifying new drugs. Expert Opin Drug Discov. 2013 Sep; 8(9):1117-26.
    View in: PubMed
    Score: 0.097
  52. Siles SA, Srinivasan A, Pierce CG, Lopez-Ribot JL, Ramasubramanian AK. High-throughput screening of a collection of known pharmacologically active small compounds for identification of Candida albicans biofilm inhibitors. Antimicrob Agents Chemother. 2013 Aug; 57(8):3681-7.
    View in: PubMed
    Score: 0.097
  53. Banerjee M, Uppuluri P, Zhao XR, Carlisle PL, Vipulanandan G, Villar CC, L?pez-Ribot JL, Kadosh D. Expression of UME6, a key regulator of Candida albicans hyphal development, enhances biofilm formation via Hgc1- and Sun41-dependent mechanisms. Eukaryot Cell. 2013 Feb; 12(2):224-32.
    View in: PubMed
    Score: 0.094
  54. Srinivasan A, Lopez-Ribot JL, Ramasubramanian AK. Candida albicans biofilm chip (CaBChip) for high-throughput antifungal drug screening. J Vis Exp. 2012 Jul 18; (65):e3845.
    View in: PubMed
    Score: 0.092
  55. Dahlan AA, Haveman CW, Ramage G, Lopez-Ribot JL, Redding SW. Sodium hypochlorite, chlorhexidine gluconate, and commercial denture cleansers as disinfecting agents against Candida albicans: An in vitro comparison study. Gen Dent. 2011 Nov-Dec; 59(6):e224-9.
    View in: PubMed
    Score: 0.087
  56. Robbins N, Uppuluri P, Nett J, Rajendran R, Ramage G, Lopez-Ribot JL, Andes D, Cowen LE. Hsp90 governs dispersion and drug resistance of fungal biofilms. PLoS Pathog. 2011 Sep; 7(9):e1002257.
    View in: PubMed
    Score: 0.086
  57. Martins M, Henriques M, Lopez-Ribot JL, Oliveira R. Addition of DNase improves the in vitro activity of antifungal drugs against Candida albicans biofilms. Mycoses. 2012 Jan; 55(1):80-5.
    View in: PubMed
    Score: 0.085
  58. Srinivasan A, Uppuluri P, Lopez-Ribot J, Ramasubramanian AK. Development of a high-throughput Candida albicans biofilm chip. PLoS One. 2011 Apr 22; 6(4):e19036.
    View in: PubMed
    Score: 0.084
  59. Martins M, Uppuluri P, Thomas DP, Cleary IA, Henriques M, Lopez-Ribot JL, Oliveira R. Presence of extracellular DNA in the Candida albicans biofilm matrix and its contribution to biofilms. Mycopathologia. 2010 May; 169(5):323-31.
    View in: PubMed
    Score: 0.077
  60. P?rez A, Pedr?s B, Murgui A, Casanova M, L?pez-Ribot JL, Mart?nez JP. Biofilm formation by Candida albicans mutants for genes coding fungal proteins exhibiting the eight-cysteine-containing CFEM domain. FEMS Yeast Res. 2006 Nov; 6(7):1074-84.
    View in: PubMed
    Score: 0.062
  61. L?pez-Ribot JL. Candida albicans biofilms: more than filamentation. Curr Biol. 2005 Jun 21; 15(12):R453-5.
    View in: PubMed
    Score: 0.056
  62. Ramage G, VandeWalle K, Bachmann SP, Wickes BL, L?pez-Ribot JL. In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies. Antimicrob Agents Chemother. 2002 Nov; 46(11):3634-6.
    View in: PubMed
    Score: 0.047
  63. Ramage G, VandeWalle K, L?pez-Ribot JL, Wickes BL. The filamentation pathway controlled by the Efg1 regulator protein is required for normal biofilm formation and development in Candida albicans. FEMS Microbiol Lett. 2002 Aug 27; 214(1):95-100.
    View in: PubMed
    Score: 0.046
  64. Kirkpatrick WR, Lopez-Ribot JL, McAtee RK, Patterson TF. Growth competition between Candida dubliniensis and Candida albicans under broth and biofilm growing conditions. J Clin Microbiol. 2000 Feb; 38(2):902-4.
    View in: PubMed
    Score: 0.039
  65. Torres NS, Abercrombie JJ, Srinivasan A, Lopez-Ribot JL, Ramasubramanian AK, Leung KP. Screening a Commercial Library of Pharmacologically Active Small Molecules against Staphylococcus aureus Biofilms. Antimicrob Agents Chemother. 2016 10; 60(10):5663-72.
    View in: PubMed
    Score: 0.031
  66. Actis L, Srinivasan A, Lopez-Ribot JL, Ramasubramanian AK, Ong JL. Effect of silver nanoparticle geometry on methicillin susceptible and resistant Staphylococcus aureus, and osteoblast viability. J Mater Sci Mater Med. 2015 Jul; 26(7):215.
    View in: PubMed
    Score: 0.028
  67. Ramage G, Tomsett K, Wickes BL, L?pez-Ribot JL, Redding SW. Denture stomatitis: a role for Candida biofilms. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004 Jul; 98(1):53-9.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support